FAKTOR – FAKTOR YANG MEMENGARUHI KESEDIAAN MASYARAKAT JABODETABEK TERHADAP VAKSINASI COVID-19 DOSIS PENGUAT KEDUA
DOI:
https://doi.org/10.19184/ikesma.v21i1.47849Keywords:
COVID-19, kesediaan, penguat kedua, SARS-CoV-2, vaksinasiAbstract
Pemerintah Indonesia berupaya mencapai kekebalan kelompok melalui program vaksinasi COVID-19. Kesediaan untuk menerima vaksinasi dosis penguat kedua perlu diteliti lebih lanjut. Tujuan penelitian ini adalah untuk mengidentifikasi faktor-faktor yang mempengaruhi kesediaan untuk menerima dosis penguat kedua vaksinasi COVID-19 di Jabodetabek, Indonesia. Penelitian sekat lintang ini menilai faktor-faktor termasuk: usia, pengeluaran, pendidikan terakhir, persepsi kesehatan fisik, komorbiditas, riwayat vaksinasi influenza, riwayat infeksi COVID-19, tingkat ketidaknyamanan setelah vaksinasi COVID-19 sebelumnya, kekhawatiran terhadap efek samping jangka panjang, persepsi perlindungan dari dosis vaksin COVID-19 sebelumnya, ketakutan terhadap COVID-19, pengetahuan mengenai COVID-19, kepatuhan terhadap protokol kesehatan dan kebersihan pribadi, kepercayaan terhadap vaksinasi COVID-19, sumber informasi, kepercayaan terhadap media sosial, verifikasi informasi, kesediaan membayar, pengetahuan dan penerimaan vaksinasi Indovac dan Inavac. Survei online dikirim melalui google form kepada orang dewasa berusia 18 tahun atau lebih di Jabodetabek dari Februari hingga Maret 2023. Data dianalisis dengan uji Chi-square, Fisher exact, Mann-Whitney, dan Regresi Logistik. Dari 182 responden, 79% bersedia menerima vaksinasi COVID-19 dosis penguat kedua. Kesediaan berhubungan signifikan dengan pengeluaran per anggota keluarga (p=0,015), tigkat pendidikan terakhir (p<0,01), persepsi kesehatan fisik (p=0,043), riwayat vaksinasi influenza (p=0,003), dan riwayat infeksi COVID-19 (p=0,004). 54,9% bersedia membayar untuk dosis penguat kedua dan mayoritas responden tidak bersedia atau tidak mengetahui tentang vaksin Indovac dan Inavac. Mayoritas responden bersedia menerima dan membayar untuk dosis penguat kedua vaksin COVID-19. Pemerintah perlu meningkatkan pengetahuan masyarakat terutama untuk vaksin buatan Indonesia sebagai dosis penguat vaksinasi COVID-19.
Downloads
References
1] Abouzid, M. et al. (2022) ‘Attitudes toward Receiving COVID-19 Booster Dose in the Middle East and North Africa (MENA) Region: A Cross-Sectional Study of 3041 Fully Vaccinated Participants’, Vaccines, 10(8), p. 1270. Available at: https://doi.org/10.3390/vaccines10081270.
2] Aldilawati, S. and Hidayat, R. (2021) ‘Edukasi Vaksinasi Covid-19 dan Penerapan 5M Dalam Menanggulangi Penularan Covid-19 di Desa Borisallo Kabupaten Gowa’, Idea Pengabdian Masyarakat, 1(01), pp. 01–06. Available at: https://doi.org/10.53690/ipm.v1i01.23.
3] Alfageeh, E.I. et al. (2021) ‘Acceptability of a COVID-19 Vaccine among the Saudi Population’, Vaccines, 9(3), p. 226. Available at: https://doi.org/10.3390/vaccines9030226.
4] Chutiyami, M. et al. (2022) ‘Subjective Reasons for COVID-19 Vaccine Hesitancy and Sociodemographic Predictors of Vaccination in Nigeria: An Online Survey’, COVID, 2(10), pp. 1329–1340. Available at: https://doi.org/10.3390/covid2100097.
5] Daniel, C.L. et al. (2022) ‘Factors associated with COVID-19 vaccination intentions among adults in the deep South’, Vaccine, 40(6), pp. 841–853. Available at: https://doi.org/10.1016/j.vaccine.2021.12.059.
6] DPR RI (2023) Komisi X DPR RI Dorong Kemendikbudristek Tuntaskan Wajib Belajar 12 Tahun. Available at: https://www.dpr.go.id/berita/detail/id/42893/t/Komisi+X+DPR+RI+Dorong+Kemendikbudristek+Tuntaskan+Wajib+Belajar+12+Tahun (Accessed: 13 March 2024).
7] Dubik, S.D. (2022) ‘Understanding the Facilitators and Barriers to COVID-19 Vaccine Uptake Among Teachers in the Sagnarigu Municipality of Northern Ghana: A Cross-Sectional Study’, Risk Management and Healthcare Policy, Volume 15, pp. 311–322. Available at: https://doi.org/10.2147/RMHP.S352584.
8] Fucaloro, S.P. et al. (2022) ‘Essential Workers’ COVID-19 Vaccine Hesitancy, Misinformation, and Informational Needs in the Republic of North Macedonia’, Vaccines, 10(3), p. 348. Available at: https://doi.org/10.3390/vaccines10030348.
9] Galanis, P. et al. (2022) ‘Predictors of Willingness of the General Public to Receive a Second COVID-19 Booster Dose or a New COVID-19 Vaccine: A Cross-Sectional Study in Greece’, Vaccines, 10(7), p. 1061. Available at: https://doi.org/10.3390/vaccines10071061.
10] Hansen, B.T. et al. (2023) ‘Coverage of primary and booster vaccination against COVID-19 by socioeconomic level: A nationwide cross-sectional registry study’, Human Vaccines & Immunotherapeutics, 19(1), p. 2188857. Available at: https://doi.org/10.1080/21645515.2023.2188857.
11] Harapan, H. et al. (2022) ‘Willingness to Pay (WTP) for COVID-19 Vaccine Booster Dose and Its Determinants in Indonesia’, Infectious Disease Reports, 14(6), pp. 1017–1032. Available at: https://doi.org/10.3390/idr14060101.
12] Karia, R. et al. (2020) ‘COVID-19 and its Modes of Transmission’, SN Comprehensive Clinical Medicine, 2(10), pp. 1798–1801. Available at: https://doi.org/10.1007/s42399-020-00498-4.
13] Kemkes RI (2016) Peraturan Menteri Kesehatan Republik Indonesia nomor 25 tahun 2016 tentang rencana aksi nasional kesehatan lanjut usia tahun 2016-2019. Jakarta: Kementerian Kesehatan RI.
14] Kemkes RI (2021) Komorbid Jadi Penyebab Terbanyak Kematian Pasien COVID-19. Available at: https://sehatnegeriku.kemkes.go.id/baca/umum/20201021/3935469/komorbid-jadi-penyebab-terbanyak-kematian-pasien-covid-19/ (Accessed: 16 February 2024).
15] Kemkes RI (2022a) Beri Perlindungan Tambahan, Lansia Diberikan Vaksin Booster Kedua. Available at: https://sehatnegeriku.kemkes.go.id/baca/umum/20221122/0341823/beri-perlindungan-tambahan-lansia-diberikan-vaksin-booster-kedua/ (Accessed: 4 February 2023).
16] Kemkes RI (2022b) Kemenkes Terbitkan Surat Edaran Pelaksanaan Vaksinasi Booster di Semua Wilayah. Available at: https://sehatnegeriku.kemkes.go.id/baca/rilis-media/20220113/4539153/kemenkes-terbitkan-surat-edaran-pelaksanaan-vaksinasi-booster-di-semua-wilayah/ (Accessed: 16 February 2024).
17] Kemkes RI (2023) Surat Edaran Nomor HK.02.02/C/380/2023 Tentang Vaksinasi COVID-19 Dosis Booster Ke-2 Bagi Kelompok Masyarakay Umum. Available at: https://www.kemkes.go.id/downloads/resources/download/SE/SE-Vaksinasi-Booster-Masyarakat-Umum.pdf (Accessed: 2 April 2023).
18] Kemkes RI (2024) Vaksin Dashboard. Available at: https://vaksin.kemkes.go.id/#/vaccines (Accessed: 18 January 2024).
19] Khubchandani, J. et al. (2021) ‘COVID-19 Vaccination Hesitancy in the United States: A Rapid National Assessment’, Journal of Community Health, 46(2), pp. 270–277. Available at: https://doi.org/10.1007/s10900-020-00958-x.
20] Lee, K.W. et al. (2022) ‘COVID-19 vaccine hesitancy and its associated factors in Malaysia’, PLOS ONE. Edited by M. Ali, 17(9), p. e0266925. Available at: https://doi.org/10.1371/journal.pone.0266925.
21] Loomba, S. et al. (2021) ‘Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA’, Nature Human Behaviour, 5(3), pp. 337–348. Available at: https://doi.org/10.1038/s41562-021-01056-1.
22] Luo, C., Chen, H.-X. and Tung, T.-H. (2022) ‘COVID-19 Vaccination in China: Adverse Effects and Its Impact on Health Care Working Decisions on Booster Dose’, Vaccines, 10(8), p. 1229. Available at: https://doi.org/10.3390/vaccines10081229.
23] Palanca-Tan, R. (2023) ‘Willingness to pay for an annual vaccine in an endemic COVID-19 scenario: a contingent valuation study in Metro Manila, Philippines’, Swiss Journal of Economics and Statistics, 159(1), p. 12. Available at: https://doi.org/10.1186/s41937-023-00116-9.
24] Pemprov DKI Jakarta (2022) Jakarta Tanggap COVID-19. Available at: https://corona.jakarta.go.id/id (Accessed: 1 November 2022).
25] Singhal, T. (2020) ‘A Review of Coronavirus Disease-2019 (COVID-19)’, The Indian Journal of Pediatrics, 87(4), pp. 281–286. Available at: https://doi.org/10.1007/s12098-020-03263-6.
26] Soares, P. et al. (2021) ‘Factors Associated with COVID-19 Vaccine Hesitancy’, Vaccines, 9(3), p. 300. Available at: https://doi.org/10.3390/vaccines9030300.
27] Syed Alwi, S.A.R. et al. (2021) ‘A survey on COVID-19 vaccine acceptance and concern among Malaysians’, BMC Public Health, 21(1), p. 1129. Available at: https://doi.org/10.1186/s12889-021-11071-6.
28] We Are Social and Hootsuite (2023) Social Report Digital Indonesia 2023. Available at: https://wearesocial.com/id/blog/2023/01/digital-2023/ (Accessed: 19 January 2024).
29] Zhao, Y. et al. (2022) ‘The global transmission of new coronavirus variants’, Environmental Research, 206, p. 12240. Available at: https://doi.org/10.1016/j.envres.2021.112240.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Vinnylia Yangsen, Soegianto Ali, Maria Mardalena Martini Kaisar, Sem Samuel Surja
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
